Search by Drug Name or NDC

NDC 59148-0046-70 Dacogen 50 mg/20mL Details

Dacogen 50 mg/20mL

Dacogen is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is DECITABINE.

MedlinePlus Drug Summary

Decitabine is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells). Decitabine is in a class of medications called hypomethylation agents. It works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow.

Related Packages: 59148-0046-70
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Decitabine Injection

Product Information

NDC	59148-0046
Product ID	59148-046_cb51f321-5384-4486-bcc5-8d86550cae3e
Associated GPIs	21300015002120
GCN Sequence Number	060839
GCN Sequence Number Description	decitabine VIAL 50 MG INTRAVEN
HIC3	V1B
HIC3 Description	ANTINEOPLASTIC - ANTIMETABOLITES
GCN	27027
HICL Sequence Number	033712
HICL Sequence Number Description	DECITABINE
Brand/Generic	Brand
Proprietary Name	Dacogen
Proprietary Name Suffix	n/a
Non-Proprietary Name	decitabine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	50
Active Ingredient Units	mg/20mL
Substance Name	DECITABINE
Labeler Name	Otsuka America Pharmaceutical, Inc.
Pharmaceutical Class	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021790
Listing Certified Through	n/a

Package

NDC 59148-0046-70 (59148004670)

Pricing Information	N/A
NDC Package Code	59148-046-70
Billing NDC	59148004670
Package	1 VIAL in 1 CARTON (59148-046-70) / 20 mL in 1 VIAL
Marketing Start Date	2006-05-02
NDC Exclude Flag	N